ciprofloxacin has been researched along with Acquired Immune Deficiency Syndrome in 36 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A rapid reduction in symptoms and bacteremia can be achieved as early as week 2 of therapy using an oral regimen of rifampin, ethambutol, clofazimine, and ciprofloxacin." | 9.07 | Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group. ( Bartok, AE; Chiu, J; Deresinski, SC; Feigal, DF; Kemper, CA; Leedom, JM; McCutchan, JA; Meng, TC; Nussbaum, J; Tilles, JG, 1992) |
| "In Kenya, researchers enrolled 53, men aged 18-60 years with chancroid who enrolled at the Nairobi City Council Special Treatment Clinic in a clinical trial to test the efficacy of fleroxacin in clinical Haemophilus ducreyi infections." | 9.06 | Evaluation of fleroxacin (RO 23-6240) as single-oral-dose therapy of culture-proven chancroid in Nairobi, Kenya. ( Cameron, DW; D'Costa, L; MacDonald, KS; Ndinya-Achola, JO; Plummer, FA; Ronald, AR, 1989) |
| "Fifty-five human immunodeficiency virus-infected patients with Salmonella bacteremia were studied to assess the rate of and causes for recurrence and to determine the influence on relapse of zidovudine, cotrimoxazole, and antimicrobial suppressive therapy according to the susceptibility of the isolates." | 7.70 | Zidovudine therapy protects against Salmonella bacteremia recurrence in human immunodeficiency virus-infected patients. ( Calderon, C; Casado, JL; Frutos, B; Guerrero, A; Martinez-Beltran, J; Navas, E; Valdezate, S, 1999) |
| "A combination of clarithromycin, ciprofloxacin, and amikacin for the treatment of Mycobacterium avium-Mycobacterium intracellulare bacteremia was evaluated in 12 AIDS patients." | 7.68 | Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. ( Caccamo, F; de Lalla, F; Marone, P; Maserati, R; Nicolin, R; Rigoli, R; Scarpellini, P, 1992) |
| "We describe four additional AIDS patients with MAC disease who had a favorable clinical and microbiological response to this regimen without developing serious adverse effects after periods ranging from 4 to 12 months." | 5.28 | Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin. ( Benson, CA; Kessler, HA; Pottage, JC; Trenholme, GM, 1991) |
| "A rapid reduction in symptoms and bacteremia can be achieved as early as week 2 of therapy using an oral regimen of rifampin, ethambutol, clofazimine, and ciprofloxacin." | 5.07 | Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group. ( Bartok, AE; Chiu, J; Deresinski, SC; Feigal, DF; Kemper, CA; Leedom, JM; McCutchan, JA; Meng, TC; Nussbaum, J; Tilles, JG, 1992) |
| "In Kenya, researchers enrolled 53, men aged 18-60 years with chancroid who enrolled at the Nairobi City Council Special Treatment Clinic in a clinical trial to test the efficacy of fleroxacin in clinical Haemophilus ducreyi infections." | 5.06 | Evaluation of fleroxacin (RO 23-6240) as single-oral-dose therapy of culture-proven chancroid in Nairobi, Kenya. ( Cameron, DW; D'Costa, L; MacDonald, KS; Ndinya-Achola, JO; Plummer, FA; Ronald, AR, 1989) |
| "Fifty-five human immunodeficiency virus-infected patients with Salmonella bacteremia were studied to assess the rate of and causes for recurrence and to determine the influence on relapse of zidovudine, cotrimoxazole, and antimicrobial suppressive therapy according to the susceptibility of the isolates." | 3.70 | Zidovudine therapy protects against Salmonella bacteremia recurrence in human immunodeficiency virus-infected patients. ( Calderon, C; Casado, JL; Frutos, B; Guerrero, A; Martinez-Beltran, J; Navas, E; Valdezate, S, 1999) |
| "A combination of clarithromycin, ciprofloxacin, and amikacin for the treatment of Mycobacterium avium-Mycobacterium intracellulare bacteremia was evaluated in 12 AIDS patients." | 3.68 | Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. ( Caccamo, F; de Lalla, F; Marone, P; Maserati, R; Nicolin, R; Rigoli, R; Scarpellini, P, 1992) |
| "We tested the activity of the new fluoroquinolone sparfloxacin (CI-978; AT 4140) against 30 strains of Mycobacterium avium complex (MAC) isolated from patients with acquired immune deficiency syndrome." | 3.68 | In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin. ( Hadley, WK; Nassos, PS; Sanders, CA; Yajko, DM, 1990) |
| "Patients with the acquired immune deficiency syndrome (AIDS) with disseminated Mycobacterium avium infection have responded poorly to treatment with rifabutine (Ansamycin) and clofazimine, in spite of the good in vitro response of M." | 3.67 | Therapeutic implications of inhibition versus killing of Mycobacterium avium complex by antimicrobial agents. ( Hadley, WK; Nassos, PS; Yajko, DM, 1987) |
| "Ten patients - two with Salmonella septicaemia associated with AIDS; one each Salmonella excretors in the convalescence stage and with Salmonella osteomyelitis; three with abdominal typhoid, and three with Salmonella enteritis - were treated with the gyrase inhibitor ciprofloxacin." | 3.67 | [Ciprofloxacin in Salmonella infection and abdominal typhoid]. ( Hoffmann, HG; Klein, E; Trautmann, M, 1986) |
| "Testing the effects of STD control on AIDS prevention is feasible in this Ugandan setting." | 2.69 | A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. ( Berkley, S; Brookmeyer, R; Gray, RH; Kelly, R; Kiwanuka, N; Li, C; Lutalo, T; McNairn, D; Nalugoda, F; Paxton, L; Quinn, TC; Serwadda, D; Sewankambo, NK; Wabwire-Mangen, F; Wawer, MJ, 1998) |
| "Ciprofloxacin (CP) is a fluoroquinolone that is highly active against diverse microorganisms." | 2.49 | Medicinal potential of ciprofloxacin and its derivatives. ( Biot, C; Castro, W; Navarro, M, 2013) |
| "Malignant otitis externa is a necrotizing infection of the external ear canal and surrounding soft tissue and bone, usually caused by Pseudomonas aeruginosa." | 1.29 | Malignant otitis externa in AIDS patients: case report and review of the literature. ( Schessel, D; Tuazon, CU; Weinroth, SE, 1994) |
| "Two patients had acquired immunodeficiency syndrome (AIDS), one was human immunodeficiency virus (HIV)-positive, and the fourth refused HIV testing." | 1.29 | Spontaneous ulcerative keratitis in immunocompromised patients. ( Aristimuño, B; Hemady, RK; Nirankari, VS; Rodrigues, MM, 1993) |
| "Seven cases of anaphylactoid reaction to ciprofloxacin have now been documented in HIV-infected patients." | 1.28 | Hypersensitivity and anaphylactoid reactions to ciprofloxacin. ( Deamer, RL; Loman, GJ; Prichard, JG, 1992) |
| "When clarithromycin was tested against three MAC strains in combination with another drug, it showed a synergistic effect only when combined with rifampicin." | 1.28 | In vitro activity of clarithromycin alone or in combination with other antimicrobial agents against Mycobacterium avium-intracellulare. Complex strains isolated from AIDS patients. ( De Gregoris, P; Fattorini, L; Hu, CQ; Iona, E; Mascellino, MT; Orefici, G; Santoro, C, 1991) |
| "We studied patients with AIDS and DMAC and compared their survival with that of AIDS patients without DMAC but with other comparable risk factors for survival." | 1.28 | Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy. ( Dubois, RE; Ellis, DA; Fann, SA; Havlik, JA; Horsburgh, CR; Kennedy, E; Thompson, SE, 1991) |
| "We describe four additional AIDS patients with MAC disease who had a favorable clinical and microbiological response to this regimen without developing serious adverse effects after periods ranging from 4 to 12 months." | 1.28 | Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin. ( Benson, CA; Kessler, HA; Pottage, JC; Trenholme, GM, 1991) |
| "Ciprofloxacin results to be an effective antibacterial agent in a high risk population." | 1.27 | Treatment of infections in non-neutropenic patients with cancer, AIDS, or renal transplant using ciprofloxacin. ( Bianchi, W; Maggiolo, F; Ohnmeiss, H, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (30.56) | 18.7374 |
| 1990's | 23 (63.89) | 18.2507 |
| 2000's | 1 (2.78) | 29.6817 |
| 2010's | 1 (2.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castro, W | 1 |
| Navarro, M | 1 |
| Biot, C | 1 |
| Wawer, MJ | 2 |
| Gray, RH | 2 |
| Quinn, T | 1 |
| Weinroth, SE | 1 |
| Schessel, D | 1 |
| Tuazon, CU | 1 |
| de la Fuente, J | 1 |
| Albo, C | 1 |
| Rodríguez, A | 1 |
| Sopeña, B | 1 |
| Martínez, C | 1 |
| Higgins, SP | 1 |
| Stedman, YF | 1 |
| Bundred, NJ | 1 |
| Woolley, PD | 1 |
| Chandiok, P | 1 |
| Chandler P [corrected to Chandiok, P] | 1 |
| Soetikno, RM | 1 |
| Johnson, JL | 1 |
| Carey, JT | 1 |
| Aristimuño, B | 1 |
| Nirankari, VS | 1 |
| Hemady, RK | 1 |
| Rodrigues, MM | 1 |
| Funke, G | 1 |
| Rosner, H | 1 |
| Marone, P | 2 |
| Bono, L | 1 |
| Carretto, E | 1 |
| Barbarini, D | 1 |
| Telecco, S | 1 |
| Sewankambo, NK | 1 |
| Serwadda, D | 1 |
| Paxton, L | 1 |
| Berkley, S | 1 |
| McNairn, D | 1 |
| Wabwire-Mangen, F | 1 |
| Li, C | 1 |
| Nalugoda, F | 1 |
| Kiwanuka, N | 1 |
| Lutalo, T | 1 |
| Brookmeyer, R | 1 |
| Kelly, R | 1 |
| Quinn, TC | 1 |
| Casado, JL | 1 |
| Valdezate, S | 1 |
| Calderon, C | 1 |
| Navas, E | 1 |
| Frutos, B | 1 |
| Guerrero, A | 1 |
| Martinez-Beltran, J | 1 |
| Hung, CC | 1 |
| Hsieh, SM | 1 |
| Hsiao, CF | 1 |
| Chen, MY | 1 |
| Sheng, WH | 1 |
| de Lalla, F | 1 |
| Maserati, R | 1 |
| Scarpellini, P | 1 |
| Nicolin, R | 1 |
| Caccamo, F | 1 |
| Rigoli, R | 1 |
| Deamer, RL | 1 |
| Prichard, JG | 1 |
| Loman, GJ | 1 |
| Berger, TG | 1 |
| Franklin, N | 1 |
| Kemper, CA | 1 |
| Meng, TC | 1 |
| Nussbaum, J | 2 |
| Chiu, J | 2 |
| Feigal, DF | 1 |
| Bartok, AE | 1 |
| Leedom, JM | 1 |
| Tilles, JG | 2 |
| Deresinski, SC | 1 |
| McCutchan, JA | 2 |
| Mascellino, MT | 1 |
| Iona, E | 1 |
| Fattorini, L | 1 |
| De Gregoris, P | 1 |
| Hu, CQ | 1 |
| Santoro, C | 1 |
| Orefici, G | 1 |
| Horsburgh, CR | 1 |
| Havlik, JA | 1 |
| Ellis, DA | 1 |
| Kennedy, E | 1 |
| Fann, SA | 1 |
| Dubois, RE | 1 |
| Thompson, SE | 1 |
| Benson, CA | 1 |
| Kessler, HA | 1 |
| Pottage, JC | 1 |
| Trenholme, GM | 1 |
| Raviglione, MC | 1 |
| Boyle, JF | 1 |
| Mariuz, P | 1 |
| Pablos-Mendez, A | 1 |
| Cortes, H | 1 |
| Merlo, A | 1 |
| Nozaki-Renard, J | 1 |
| Iino, T | 1 |
| Sato, Y | 1 |
| Marumoto, Y | 1 |
| Ohta, G | 1 |
| Furusawa, M | 1 |
| Yajko, DM | 2 |
| Sanders, CA | 1 |
| Nassos, PS | 2 |
| Hadley, WK | 2 |
| Rivas Lacarte, MP | 1 |
| Pumarola Segura, F | 1 |
| Bozzette, S | 1 |
| Young, LS | 1 |
| Leedom, J | 1 |
| Heseltine, PN | 1 |
| Pedro-Botet Montoya, J | 1 |
| Tomás Vecina, S | 1 |
| Soriano Giménez, JC | 1 |
| Rubiés-Prat, J | 1 |
| MacDonald, KS | 1 |
| Cameron, DW | 1 |
| D'Costa, L | 1 |
| Ndinya-Achola, JO | 1 |
| Plummer, FA | 1 |
| Ronald, AR | 1 |
| Wurtz, RM | 1 |
| Abrams, D | 1 |
| Becker, S | 1 |
| Jacobson, MA | 2 |
| Mass, MM | 1 |
| Marks, SH | 1 |
| Hahn, SM | 1 |
| Gerberding, JL | 1 |
| Lee, B | 1 |
| Sande, MA | 1 |
| Altés, J | 1 |
| Gascó, J | 1 |
| de Antonio, J | 1 |
| Salas, A | 1 |
| Villalonga, C | 1 |
| Valainis, G | 1 |
| Thomas, D | 1 |
| Pankey, G | 1 |
| Maggiolo, F | 1 |
| Bianchi, W | 1 |
| Ohnmeiss, H | 1 |
| Connolly, MJ | 1 |
| Snow, MH | 1 |
| Ingham, HR | 1 |
| Klein, E | 1 |
| Trautmann, M | 1 |
| Hoffmann, HG | 1 |
| Masur, H | 1 |
| Tuazon, C | 1 |
| Gill, V | 1 |
| Grimes, G | 1 |
| Baird, B | 1 |
| Fauci, AS | 1 |
| Lane, HC | 1 |
2 reviews available for ciprofloxacin and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Medicinal potential of ciprofloxacin and its derivatives.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Ciprofloxacin; Humans; Malaria, Falciparu | 2013 |
Rahnella aquatilis bacteremia in an HIV-infected intravenous drug abuser.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Gram-Ne | 1995 |
3 trials available for ciprofloxacin and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; Anti-Infective Agents; | 1998 |
Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Amikacin; Anti-Infective Agents; Ba | 1992 |
Evaluation of fleroxacin (RO 23-6240) as single-oral-dose therapy of culture-proven chancroid in Nairobi, Kenya.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; | 1989 |
31 other studies available for ciprofloxacin and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
AIDS intervention in Uganda.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cipr | 1995 |
Malignant otitis externa in AIDS patients: case report and review of the literature.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Bone Diseases; Ciprofloxacin; Huma | 1994 |
Bordetella bronchiseptica pneumonia in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Bordetella bronchi | 1994 |
Periareolar breast abscess due to Pseudomonas aeruginosa in an HIV antibody positive male.
Topics: Abscess; Acquired Immunodeficiency Syndrome; Adult; Breast Diseases; Ciprofloxacin; Humans; Male; Ps | 1994 |
Ciprofloxacin-induced anaphylactoid reaction in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anaphylaxis; Ciprofloxacin; Humans; Male | 1993 |
Spontaneous ulcerative keratitis in immunocompromised patients.
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adult; Amikacin; Amphotericin B; Candid | 1993 |
Rapid drug susceptibility of Mycobacterium avium complex using a fluorescence quenching method.
Topics: Acquired Immunodeficiency Syndrome; Agar; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Az | 1997 |
Zidovudine therapy protects against Salmonella bacteremia recurrence in human immunodeficiency virus-infected patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amoxicillin; Anti-HIV Agents; Anti-Infective Agents; Bact | 1999 |
Risk of recurrent non-typhoid Salmonella bacteraemia after early discontinuation of ciprofloxacin as secondary prophylaxis in AIDS patients in the era of highly active antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Infecti | 2001 |
MAC management.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Antitubercular Agents; Ciprofloxacin; Clarithromycin; | 1996 |
Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Bacteremia; Cause of Death; Ciprofloxacin; Clar | 1992 |
Hypersensitivity and anaphylactoid reactions to ciprofloxacin.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Anaphylaxis; Ciprofloxacin; Drug Hy | 1992 |
Anaphylactoid reaction to ciprofloxacin in a patient infected with the human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anaphylaxis; Ciprofloxacin; Edema; Humans; Male; Salmonel | 1992 |
In vitro activity of clarithromycin alone or in combination with other antimicrobial agents against Mycobacterium avium-intracellulare. Complex strains isolated from AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; | 1991 |
Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Antibiotics, Antitubercular; Ciprofloxaci | 1991 |
Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Antitubercular Agents; Ciprofloxacin; Clofazimi | 1991 |
Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Bacteriophage Typing; Ciprofloxacin; Drug Resista | 1990 |
Fluoroquinolones protect the human lymphocyte CEM cell line from HIV-1-mediated cytotoxicity.
Topics: Acquired Immunodeficiency Syndrome; Cell Line; Cell Survival; Ciprofloxacin; Enoxacin; HIV-1; Humans | 1990 |
In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin.
Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; Ciprofloxacin; Drug Synergism; Ethambutol | 1990 |
[Malignant otitis externa and HIV antibodies. A case report].
Topics: Acquired Immunodeficiency Syndrome; Adult; Ciprofloxacin; Drug Therapy, Combination; Gentamicins; HI | 1990 |
Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Amikacin; Chemical and Drug Induced Liver | 1990 |
[Ciprofloxacin: a solution for recurrent bacteremia caused by Salmonella non typhi in acquired immunodeficiency syndrome?].
Topics: Acquired Immunodeficiency Syndrome; Ciprofloxacin; Humans; Male; Middle Aged; Recurrence; Salmonella | 1989 |
Anaphylactoid drug reactions to ciprofloxacin and rifampicin in HIV-infected patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anaphylaxis; Ciprofloxacin; Humans; Male; Rifampin; Tuber | 1989 |
Ciprofloxacin for Salmonella bacteremia in the acquired immunodeficiency syndrome (AIDS).
Topics: Acquired Immunodeficiency Syndrome; Adult; Ciprofloxacin; Humans; Male; Middle Aged; Recurrence; Sal | 1989 |
Ciprofloxacin and delirium.
Topics: Acquired Immunodeficiency Syndrome; Ciprofloxacin; Delirium; Humans; Male; Middle Aged; Pneumonia | 1989 |
Penetration of ciprofloxacin into cerebrospinal fluid.
Topics: Acquired Immunodeficiency Syndrome; Aged; Anti-Bacterial Agents; Ciprofloxacin; Female; Humans; Quin | 1986 |
Therapeutic implications of inhibition versus killing of Mycobacterium avium complex by antimicrobial agents.
Topics: Acquired Immunodeficiency Syndrome; Ciprofloxacin; Clofazimine; Humans; Mycobacterium avium; Rifabut | 1987 |
Treatment of infections in non-neutropenic patients with cancer, AIDS, or renal transplant using ciprofloxacin.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Aged, 80 and over; Bacterial Infections; Ciprofloxa | 1988 |
Ciprofloxacin treatment of recurrent Salmonella typhimurium septicaemia in a patient with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Ciprofloxacin; Humans; Male; Recurrence; Salmonella Infec | 1986 |
[Ciprofloxacin in Salmonella infection and abdominal typhoid].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Carrier State; Ciprofloxacin; Female; Humans; Male; | 1986 |
Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clofazimine; Cyc | 1987 |